Safety and efficacy of the blood-stage malaria vaccine RH5.1/Matrix-M in Burkina Faso: interim results of a double-blind, randomised, controlled phase 2b trial in children

Hamtandi M. Natama, Jo Salkeld, Athanase Somé, Seyi Soremekun, Salou Diallo, Ousmane Traoré, Toussaint Rouamba, Florence Ouédraogo, Edouard Ouédraogo, K. Carine Sonia Daboné, Nadine A. Koné, Z. Michael John Compaoré, Miguel Kafando, Massa dit Achille Bonko, Fabé Konaté, Hermann Sorgho, Carolyn M. Nielsen, Dimitra Pipini, Ababacar Diouf, Lloyd D. W. King, Umesh Shaligram, Carole A. Long, Jee-Sun Cho, Alison M. Lawrie, Katherine Skinner, Rachel Roberts, Kazutoyo Miura, John Bradley, Sarah E. Silk, Simon J. Draper, Halidou Tinto, Angela M. Minassian
doi: https://doi.org/10.1101/2024.10.15.24315473

Article Information

doi 
https://doi.org/10.1101/2024.10.15.24315473
History 
  • October 16, 2024.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. Hamtandi M. Natama1,*,
  2. Jo Salkeld2,3,4,*,
  3. Athanase Somé1,
  4. Seyi Soremekun5,
  5. Salou Diallo1,
  6. Ousmane Traoré1,
  7. Toussaint Rouamba1,
  8. Florence Ouédraogo1,
  9. Edouard Ouédraogo1,
  10. K. Carine Sonia Daboné1,
  11. Nadine A. Koné1,
  12. Z. Michael John Compaoré1,
  13. Miguel Kafando1,
  14. Massa dit Achille Bonko1,
  15. Fabé Konaté1,
  16. Hermann Sorgho1,
  17. Carolyn M. Nielsen2,3,
  18. Dimitra Pipini2,3,
  19. Ababacar Diouf6,
  20. Lloyd D. W. King2,3,
  21. Umesh Shaligram7,
  22. Carole A. Long6,
  23. Jee-Sun Cho2,3,4,
  24. Alison M. Lawrie4,8,
  25. Katherine Skinner2,3,
  26. Rachel Roberts2,3,4,
  27. Kazutoyo Miura6,
  28. John Bradley5,
  29. Sarah E. Silk2,3,
  30. Simon J. Draper2,3,8,†,
  31. Halidou Tinto1,† and
  32. Angela M. Minassian2,3,4,8,#,†
  1. 1Unité de Recherche Clinique de Nanoro, Institut de Recherche en Sciences de la Santé, Nanoro, Burkina Faso
  2. 2Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, OX1 3QU, UK
  3. 3Kavli Institute for Nanoscience Discovery, Dorothy Crowfoot Hodgkin Building, University of Oxford, Oxford, OX1 3QU, UK
  4. 4Centre for Clinical Vaccinology and Tropical Medicine, Jenner Institute, University of Oxford, Old Road Campus, Oxford, OX3 7LE, UK
  5. 5London School of Hygiene and Tropical Medicine, London, WC1E 7HT, UK
  6. 6Laboratory of Malaria and Vector Research, NIAID/NIH, Rockville, MD 20852, USA
  7. 7Serum Institute of India Pvt. Ltd., Pune, India
  8. 8NIHR Oxford Biomedical Research Centre, Oxford, UK
  1. ↵#Correspondence to: Angela M. Minassian, Department of Biochemistry, University of Oxford, Oxford, OX1 3QU, UK ; angela.minassian{at}bioch.ox.ac.uk
Back to top
Posted October 16, 2024.
Download PDF

Supplementary Material

Data/Code
Email
Safety and efficacy of the blood-stage malaria vaccine RH5.1/Matrix-M in Burkina Faso: interim results of a double-blind, randomised, controlled phase 2b trial in children
Hamtandi M. Natama, Jo Salkeld, Athanase Somé, Seyi Soremekun, Salou Diallo, Ousmane Traoré, Toussaint Rouamba, Florence Ouédraogo, Edouard Ouédraogo, K. Carine Sonia Daboné, Nadine A. Koné, Z. Michael John Compaoré, Miguel Kafando, Massa dit Achille Bonko, Fabé Konaté, Hermann Sorgho, Carolyn M. Nielsen, Dimitra Pipini, Ababacar Diouf, Lloyd D. W. King, Umesh Shaligram, Carole A. Long, Jee-Sun Cho, Alison M. Lawrie, Katherine Skinner, Rachel Roberts, Kazutoyo Miura, John Bradley, Sarah E. Silk, Simon J. Draper, Halidou Tinto, Angela M. Minassian
medRxiv 2024.10.15.24315473; doi: https://doi.org/10.1101/2024.10.15.24315473
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area